Michael Kunicki

5PUBLICATIONS
33CO-AUTHORS
Gene and molecular therapyHaematological tumoursSolid tumoursAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 13, 2024
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas.

Michelle Monje, Jasia Mahdi, Robbie Majzner

|Sep 15, 2022
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.

Liora M Schultz, Anne Eaton, Christina Baggott

|Feb 07, 2022
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.

Robbie G Majzner, Sneha Ramakrishna, Kristen W Yeom

|Dec 09, 2021
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.

Liora M Schultz, Christina Baggott, Snehit Prabhu

Pageof 1